| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/16/2013 | CN102872064A Method for extracting alpha-glucosidase activity inhibitor from lycium barbarum seeds and residues after extraction of lycium barbarum oil from lycium barbarum seeds and application thereof |
| 01/16/2013 | CN102872063A Application of dammarane sapogenin compound |
| 01/16/2013 | CN102872062A Medicinal composition for treating or preventing obesity and metabolic syndromes |
| 01/16/2013 | CN102872061A Composition of creatine phosphate and arginine |
| 01/16/2013 | CN102872060A Application of Gypensapogenin B to preparing drugs for treating or preventing canker sores |
| 01/16/2013 | CN102872059A Application of Gypensapogenin B to preparing drugs for resisting human funguses |
| 01/16/2013 | CN102872058A Application of Gypensapogenin A to preparing drugs for preventing and treating liver injury |
| 01/16/2013 | CN102872057A Application of Gypensapogenin A to preparing drugs for treating yellow fever virus infection |
| 01/16/2013 | CN102872056A Application of Gypensapogenin A to preparing drugs for treating or preventing canker sores |
| 01/16/2013 | CN102872055A Application of gypensapogenin B to anti-tubercle bacillus drugs |
| 01/16/2013 | CN102872054A Application of gypensapogenin A to pancreatic fibrosis prevention and treatment drugs |
| 01/16/2013 | CN102872053A Application of gypensapogenin A to anti-herpes simplex virus drugs |
| 01/16/2013 | CN102872052A Application of gypensapogenin B to Alzheimer disease treatment drugs |
| 01/16/2013 | CN102872051A Application of gypensapogenin A to antidepressant drugs |
| 01/16/2013 | CN102872050A Application of gypensapogenin A to Alzheimer disease treatment drugs |
| 01/16/2013 | CN102872049A Application of gypensapogenin A to anti-tubercle bacillus drugs |
| 01/16/2013 | CN102872048A Application of gypensapogenin B to ischemic brain injury treatment drugs |
| 01/16/2013 | CN102872047A Application of Gypensapogenin A in medicament for increasing level of blood platelets |
| 01/16/2013 | CN102872046A Application of gypensapogenin A to dengue virus infection treatment drugs |
| 01/16/2013 | CN102872045A Application of gypensapogenin A to hypoglycemic drugs |
| 01/16/2013 | CN102872044A Application of Gypensapogenin A in medicaments for vasodilator |
| 01/16/2013 | CN102872043A Application of Gypensapogenin B in medicament of increasing level of leukocyte |
| 01/16/2013 | CN102872042A Application of Gypensapogenin B in medicaments for treating or preventing renal fibrosis |
| 01/16/2013 | CN102872041A Application of Gypensapogenin A in medicaments for preventing and treating renal insufficiency |
| 01/16/2013 | CN102872040A Application of Gypensapogenin B in medicament for increasing level of blood platelets |
| 01/16/2013 | CN102872039A Application of Gypensapogenin B in medicaments for promoting insulin secretion |
| 01/16/2013 | CN102872038A Application of Gypensapogenin B in medicaments against herpes viruses |
| 01/16/2013 | CN102872037A Application of Gypensapogenin B in medicaments against aseptic inflammation |
| 01/16/2013 | CN102872036A Application of Gypensapogenin A in medicament for increasing level of red blood cells |
| 01/16/2013 | CN102872035A Application of Gypensapogenin A in medicaments against platelet aggregation |
| 01/16/2013 | CN102872034A Application of Gypensapogenin B in medicaments for treating rhinitis |
| 01/16/2013 | CN102872033A Application of Gypensapogenin A in medicaments for treating or preventing chronic heart failure renal fibrosis |
| 01/16/2013 | CN102872032A Application of Gypensapogenin B in anti-hypoxia drugs |
| 01/16/2013 | CN102872031A Application of Gypensapogenin B in medicaments for treating or preventing chronic heart failure |
| 01/16/2013 | CN102872030A Application of Gypensapogenin B in antibacterial drugs |
| 01/16/2013 | CN102872029A Application of Gypensapogenin B in medicaments for promoting small intestine peristalsis |
| 01/16/2013 | CN102872028A Application of Gypensapogenin A in medicaments against helicobacter pylori |
| 01/16/2013 | CN102872027A Preparation method for medicine granules for treating asthma and pneumonopathy and preparation method for suction type compound aerosol of granules |
| 01/16/2013 | CN102872026A Novel purpose for compound |
| 01/16/2013 | CN102872025A Application of oleanolic acid in preparing anti-hepatitis c virus drugs and reagents |
| 01/16/2013 | CN102872024A Misoprostol medicine combination used in mouths |
| 01/16/2013 | CN102872023A Lung carcinoma cell inhibitor and preparation method of lung carcinoma cell inhibitor |
| 01/16/2013 | CN102872022A Nicotinic receptor agonists for the treatment of inflammatory diseases |
| 01/16/2013 | CN102872021A Medicinal composition containing ceftezole sodium compound and preparation method for medicinal composition |
| 01/16/2013 | CN102872020A Inhibitor of pai-1 production |
| 01/16/2013 | CN102872019A Efavirenz preparation adopting micronization technology |
| 01/16/2013 | CN102872018A Tyrosine kinase irreversible inhibitor and preparation method and applications thereof |
| 01/16/2013 | CN102872017A Use of 6-(4-difluoromethoxy)-3methoxyphenyl)pyridazine-3(2H)-one in preparation of antitumor drugs |
| 01/16/2013 | CN102872016A Medicine combination |
| 01/16/2013 | CN102872015A Stephanotis total alkaloid extract as well as preparation method and application thereof |
| 01/16/2013 | CN102872014A Compound florfenicol composition and preparation process and application thereof |
| 01/16/2013 | CN102872013A Anti-parasitic disease compound Triclabendazole granule for flocks and herds and preparation method for anti-parasitic disease compound Triclabendazole granule |
| 01/16/2013 | CN102872012A Compound capable of inhibiting protein kinase and application thereof |
| 01/16/2013 | CN102872011A Pharmaceutical composition comprising (S)-4-hydroxy-2-oxo-1-pyrrolidine acetamide |
| 01/16/2013 | CN102872010A Application of Aphanamixoid A in drugs for treating ovarian cancer |
| 01/16/2013 | CN102872009A Application of Eryngiolide A in drugs for inhibiting liver fibroblast cell proliferation |
| 01/16/2013 | CN102872008A Applications of Aphanamixoid A in medicaments for treating leukemia |
| 01/16/2013 | CN102872007A Application of Eryngiolide A in medicaments resisting human body fungi |
| 01/16/2013 | CN102872006A Applications of tagitinin a and derivatives thereof in treatment of metabolic diseases |
| 01/16/2013 | CN102872005A Application of glycyrrhizin to preparation of medicine for treating pneumonia |
| 01/16/2013 | CN102872004A Application of naringenin in preparation of medicine for curing pneumonia |
| 01/16/2013 | CN102872003A Application of apigenin on preparation of medicine for treating pneumonia |
| 01/16/2013 | CN102872002A Hydroxysafflor yellow A oil solution and preparation method and application thereof |
| 01/16/2013 | CN102872001A Compound serving as PPAR gamma ligand and application thereof |
| 01/16/2013 | CN102872000A Application of taxane monoalkoxy derivant in preparation of antitumor drug |
| 01/16/2013 | CN102871999A Application of 10-monoalkoxy taxad compound derivatives to preparation of antineoplastic drugs |
| 01/16/2013 | CN102871998A Application of nafamostat mesilate in preparing drugs for preventing and curing ischemic cerebral apoplexy |
| 01/16/2013 | CN102871997A Controlled-release medicinal composition containing demethyl venlafaxine benzoate compounds |
| 01/16/2013 | CN102871996A Antibiotic composition and application thereof |
| 01/16/2013 | CN102871995A Medicinal composition containing diclofenac sodium and preparation method thereof |
| 01/16/2013 | CN102871994A Flurbiprofen acetaminophen ester cyclodextrin inclusion compound and preparation method thereof |
| 01/16/2013 | CN102871993A Novel application of bitter |
| 01/16/2013 | CN102871992A Application of 3,5-dinitrobenzene formamide in preparation of anti-tuberculosis medicaments |
| 01/16/2013 | CN102871991A Application of dimethyldiguanide in drugs taking protective effect on chemoradiotherapy injury |
| 01/16/2013 | CN102871990A Pharmaceutical application of resveratrol |
| 01/16/2013 | CN102871989A External preparation containing either honokiol or pharmaceutically acceptable salt of honokiol and new application |
| 01/16/2013 | CN102871987A Method for providing fast relief for user through nicotine chewing gum |
| 01/16/2013 | CN102871984A Phenylephrine hydrochloride oral instant membrane and preparation method thereof |
| 01/16/2013 | CN102871983A Gambogic acid colon-specific controlled release tablet and preparation method thereof |
| 01/16/2013 | CN102871981A Tablet medicine compound containing levetiracetam |
| 01/16/2013 | CN102871980A Enteric-coated tablet of S-pantoprazole or salt of S-pantoprazole, and preparation method thereof |
| 01/16/2013 | CN102871979A Slow release pharmaceutical preparation and method of administering same |
| 01/16/2013 | CN102871978A Levosulpiride tablets and preparation method thereof |
| 01/16/2013 | CN102871977A Ulipristal acetate dispersible tablet and preparation method thereof |
| 01/16/2013 | CN102871976A Tablet containing roflumilast as active ingredients and preparation method of tablet |
| 01/16/2013 | CN102871974A Paclitaxel magnetic nanoparticle as well as preparation method and purpose of paclitaxel magnetic nanoparticle |
| 01/16/2013 | CN102871973A Omeprazole sodium freeze-drying preparation and preparation method thereof |
| 01/16/2013 | CN102871972A Lyophilized lansoprazole preparation and preparation method thereof |
| 01/16/2013 | CN102871971A Freeze-dried powder injection of vitamin B6 and preparation method thereof |
| 01/16/2013 | CN102871970A Puerarin oral adhesion microballoon spheres and preparation method thereof |
| 01/16/2013 | CN102871968A Preparation method for sildenafil rhubarb hydrochloric acid salt medicine granules and preparation method for suction type aerosol of gradules |
| 01/16/2013 | CN102871967A Preparation of salified medicinal particles of levosalbutamol and traditional Chinese medicine monomer and preparation of particle inhalable aerosol |
| 01/16/2013 | CN102871966A Nano drug carrier particles for improving bioavailability of rapamycin and preparation method thereof |
| 01/16/2013 | CN102871965A Preparation method of tumor treatment medicine spray |
| 01/16/2013 | CN102871964A Stable and efficient propofol middle/long-chain fat emulsion injection and preparation method thereof |
| 01/16/2013 | CN102871963A Paclitaxel lipid nanoparticle injection liquid with anti-tumor activity |
| 01/16/2013 | CN102871962A Drug combination of mezlocillin sodium for injection and preparation method of same |
| 01/16/2013 | CN102871961A Injection containing tirofiban |
| 01/16/2013 | CN102871960A Lentinan injection and preparation method thereof |
| 01/16/2013 | CN102871959A Stable (S)-4-hydroxy-2-oxo-1-pyrrolidine acetamide pharmaceutical composition |